Literature DB >> 8653685

Frequent microsatellite instability in epithelial borderline ovarian tumors.

J Tangir1, N S Loughridge, R S Berkowitz, M G Muto, D A Bell, W R Welch, S C Mok.   

Abstract

To further define the genetic events that could lead to the development of borderline ovarian tumors (BOTs), we analyzed 13 microsatellite markers on chromosomes 3p and q in 18 BOTs and compared the results to 31 serous invasive epithelia] ovarian cancers (IEOCs). Five of the 18 BOTs showed microsatellite instability (MSI) at one or more loci, compared to only 2 of the 31 IEOCs studied (P < 0.04). In two of these five BOTs, MSI was found in multiple loci. All BOTs with MSI were serous, while none of the mucinous type showed any alteration. Loss of heterozygosity was found in only 1 of the 18 BOTs, but in 12 of the 31 IEOCs (P < 0.01). This first report of a relatively high percentage of MSI in BOTs opens a wide spectrum of new hypotheses for borderline ovarian tumorigenesis as well as several new research avenues.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8653685

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Expression of a homeobox gene (SIX5) in borderline ovarian tumours.

Authors:  C Winchester; S Robertson; T MacLeod; K Johnson; M Thomas
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

2.  Genomic aberrations in borderline ovarian tumors.

Authors:  Francesca Micci; Lisbeth Haugom; Terje Ahlquist; Hege K Andersen; Vera M Abeler; Ben Davidson; Claes G Trope; Ragnhild A Lothe; Sverre Heim
Journal:  J Transl Med       Date:  2010-02-26       Impact factor: 5.531

Review 3.  Cancer and forensic microsatellites.

Authors:  Karen Page; Eleanor A M Graham
Journal:  Forensic Sci Med Pathol       Date:  2008-02-02       Impact factor: 2.007

Review 4.  Systematic review and meta-analysis of ovarian cancers: estimation of microsatellite-high frequency and characterization of mismatch repair deficient tumor histology.

Authors:  Tuya Pal; Jenny Permuth-Wey; Ambuj Kumar; Thomas A Sellers
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

Review 5.  A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer.

Authors:  Tuya Pal; Jenny Permuth-Wey; Thomas A Sellers
Journal:  Cancer       Date:  2008-08-15       Impact factor: 6.860

Review 6.  The biology of ovarian cancer: new opportunities for translation.

Authors:  Robert C Bast; Bryan Hennessy; Gordon B Mills
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

7.  Mismatch repair and treatment resistance in ovarian cancer.

Authors:  Jozien Helleman; Iris L van Staveren; Winand N M Dinjens; Patricia F van Kuijk; Kirsten Ritstier; Patricia C Ewing; Maria E L van der Burg; Gerrit Stoter; Els M J J Berns
Journal:  BMC Cancer       Date:  2006-07-31       Impact factor: 4.430

8.  Tumor spreading to the contralateral ovary in bilateral ovarian carcinoma is a late event in clonal evolution.

Authors:  Francesca Micci; Lisbeth Haugom; Terje Ahlquist; Vera M Abeler; Claes G Trope; Ragnhild A Lothe; Sverre Heim
Journal:  J Oncol       Date:  2009-09-15       Impact factor: 4.375

9.  Clinical significance of microsatellite instability in sporadic epithelial ovarian tumors.

Authors:  Bo-Sung Yoon; Young-Tae Kim; Jae-Hoon Kim; Sang-Wun Kim; Eun-Ji Nam; Nam-Hoon Cho; Jae-Wook Kim; Sunghoon Kim
Journal:  Yonsei Med J       Date:  2008-04-30       Impact factor: 2.759

10.  Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes.

Authors:  Sally M Hunter; Michael S Anglesio; Georgina L Ryland; Raghwa Sharma; Yoke-Eng Chiew; Simone M Rowley; Maria A Doyle; Jason Li; C Blake Gilks; Phillip Moss; Prue E Allan; Andrew N Stephens; David G Huntsman; Anna deFazio; David D Bowtell; Kylie L Gorringe; Ian G Campbell
Journal:  Oncotarget       Date:  2015-11-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.